http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-027070-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2009-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2778132ca6046eabfbcaa47acb9ee411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_977e847b89af3c6910289bf6a332a1b6
publicationDate 2017-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-027070-B1
titleOfInvention ANTI-TUMOR COMBINATIONS CONTAINING ANTIBODIES SPECIFICALLY RECOGNIZING CD38 AND CYTARABINES
abstract The invention relates to a pharmaceutical combination, which is intended for the treatment of a malignant tumor. The composition contains an antibody that specifically recognizes CD38 and cytarabine. In addition, a method for the treatment of a malignant tumor, which includes the introduction of the specified combination to an individual in need. The invention can be effectively used in the treatment of malignant tumors.
priorityDate 2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006099875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9962526-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1914242-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445794
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID167337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123847
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551394
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968021
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555131
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID145754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11321969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411320770
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID167337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25774
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID145754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551883
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8847

Total number of triples: 53.